United States v. DePuy Orthopaedics, Inc.

CourtDistrict Court, D. Massachusetts
DecidedDecember 8, 2021
Docket1:12-cv-10896
StatusUnknown

This text of United States v. DePuy Orthopaedics, Inc. (United States v. DePuy Orthopaedics, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. DePuy Orthopaedics, Inc., (D. Mass. 2021).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS THE UNITED STATES OF AMERICA and THE STATE OF NEW YORK CIVIL ACTION No. 12-10896-MPK1 ex rel. DR. ANTONI NARGOL & DR. DAVID LANGTON, Relators, v. DEPUY ORTHOPAEDICS, INC., DEPUY, INC., and JOHNSON & JOHNSON SERVICES, INC., Defendants. MEMORANDUM AND ORDER ON DEPUY’S MOTION FOR RECONSIDERATION (#545). KELLEY, U.S.M.J. I. Introduction. In May 2012, Dr. Antoni Nargol and Dr. David Langton brought this qui tam action against DePuy Orthopaedics, Inc., DePuy, Inc., and Johnson & Johnson Services, Inc. (collectively, DePuy) under the False Claims Act (FCA), 31 U.S.C. §§ 3729 et seq., and the New York state false claims act. (##1; 219.)2 At issue is the metal-on-metal (MoM) hip replacement device DePuy manufactured under its “Pinnacle” product line (the Pinnacle or the Pinnacle device). (#219 ¶ 6.) Relators allege that over a five-year period, DePuy illegally promoted and sold a significant

1 With the parties’ consent, this case has been assigned to the undersigned for all purposes, including trial and the entry of judgment, pursuant to 28 U.S.C. § 636(c). (#318.) 2 The Department of Justice (DOJ) declined to intervene on behalf of the United States. (#32.) Previous claims arising under the laws of other states have been dismissed. See #204 at 31. number of Pinnacle devices that fell outside FDA-approved manufacturing specifications, causing false claims to be submitted to Medicare and Medicaid. See id. ¶¶ 88, 104, 179-181, 349. A key issue in this action is that relators previously served as experts and consultants in multi-district litigation (MDL) involving the Pinnacle device and another MoM hip replacement

device manufactured by DePuy, called “ASR.” In those roles, relators had access to confidential information subject to protective orders. (##103 at 18; 522-21.) Relators have been warned by multiple courts that they are required to comply with the protective and court orders that govern their use of that confidential information. See, e.g., ##101; 103 at 18; 249; 414. In addition, they have been chastised repeatedly for failing to comply with those orders. See, e.g., ##104 at 22, 27; 103 at 18; 414. DePuy moved to strike allegations and to dismiss the case, (#519), citing relators’ use of confidential information in their second amended complaint as a basis for dismissal. The court denied the motion (#542); DePuy moved for reconsideration (#545). For the reasons discussed below, DePuy’s motion (#545) is ALLOWED. II. Factual Background.

A. Relators’ Claims. DePuy is in the business of designing, manufacturing, and distributing MoM hip replacement devices used to treat medical conditions such as late-stage degenerative hip disease, hip joint damage, and osteoarthritis. (#219 ¶ 73.) Relators describe themselves as “two of the most prominent experts in MoM surgical technique and engineering technology.” Id. ¶ 23. Throughout the 2000s, relators used DePuy MoM devices such as the Pinnacle and ASR to treat hip conditions in many patients. Id. ¶ 24. These devices included a metal head, cup, and liner, which together mimic the cup and ball of a hip joint. Id. ¶¶ 6, 148, 154. As Relator Langton began noticing problems with the Pinnacle, he gathered data on explanted devices. (#219 ¶ 70.)3 He examined over 250 explanted and unused Pinnacle devices and collected measurements of the explants in a database. Id. Relators hired QA Consulting (QA) to perform a statistical analysis of the explant data. Id. ¶¶ 344, 346. They allege that, “[b]ased upon

QA’s statistical analysis, DePuy’s manufacturing process fails to produce implant heads within specification 14.93% of the time and implant liners 50.41% of the time.” Id. ¶ 349. Relying in large part on QA’s analysis, relators’ claims are premised on the allegation “that DePuy falsely palmed off devices that, due to latent manufacturing defects, materially deviated from the design specification of the FDA-approved Pinnacle MoM device.” (#204 at 6); see also U.S. ex rel. Nargol v.DePuy Orthopaedics, Inc., 865 F.3d 29, 32 (1st Cir. 2017). B. Relators’ Confidentiality Obligations. 1. ASR MDL. In 2010, in response to high failure rates for the ASR device, DePuy announced a recall. (#219 ¶ 55 & n.4.) At the same time, the company faced a rash of product liability lawsuits

regarding the ASR device that were consolidated into an MDL. Id. ¶¶ 56-57; see In re: DePuy Orthopaedics, Inc., ASR Hip Implant Prods. Liab. Litig., No. 10-md-2197 (N.D. Ohio). Prior to bringing this lawsuit, relators served as testifying experts or fact witnesses, or otherwise provided expert assistance, in many product liability and personal injury cases against DePuy, including the ASR MDL. Id. ¶¶ 68, 72. Beginning around May 2012, plaintiffs’ counsel in the ASR MDL provided relators with confidential DePuy documents to assist them in preparing for their expert

3 The Pinnacle device was made in multiple sizes; the product at issue in this case is the 36mm Pinnacle device. (#219 ¶ 359.) testimony there. (#103 at 12.) These documents were subject to a protective order which bound both relators to certain confidentiality obligations. Id. 2. Pinnacle MDL. Since 2011, “more than 5,000 personal injury actions have been filed by patients who have

been injured by the Pinnacle device.” (#219 ¶ 58.) Like the ASR cases, these cases were consolidated into an MDL. Id.; see In re: DePuy Orthopaedics, Inc., Pinnacle Hip Implant Prods. Liab. Litig., No. 11-md-2244 (N.D. Tex.). Langton consulted with plaintiffs’ counsel in support of the Pinnacle MDL but was not formally retained as an expert. (#529 at 19 n.25.) Although Langton was not formally retained, he consulted with plaintiffs’ counsel and experts, received remuneration for his time and efforts, and had access to materials that would not otherwise have been available to someone who was not associated with the litigation. See, e.g., #522-11 at 2 (email communications between Langton and plaintiffs’ counsel, discussing documents he wanted to review and whether he would be billing plaintiffs’ counsel for his time). On November 15, 2013, he signed a confidentiality agreement, indicating that he had read the Pinnacle MDL’s stipulated

protective order, understood its terms, and “agree[d], upon threat of penalty of contempt, to be bound by such terms.” (#522-21 at 7.) 3. Relators’ Repeated Violations of Confidentiality Orders. In July 2014, relators disclosed to this court that they had included in their complaint confidential information subject to protective orders in both MDLs. (##34; 37 at 3-4.) Judge Saylor, who was presiding over the case at that time, granted relators leave to amend the complaint so as to remove the offending material. (#101). The second amended complaint was required to be accompanied by affidavits from relators sworn to under the pains of perjury that certify that the second amended complaint does not violate any relevant court order, including the protective orders issued in the MDL proceedings in the Northern District of Ohio or the Northern District of Texas or the order issued by the court in Ohio on January 5, 2015. Id. (emphasis added.) Relators filed their second amended complaint with the required accompanying affidavits on May 4, 2015. (##115-3; 115-4.)4 In 2015, relators asked the presiding judge of the ASR MDL, Judge Katz, to relieve them of their obligations under the protective order in that case. (#103 at 11.) They admitted that in contravention of the protective order, between May 2012 and June 2014, they had given confidential documents and information to the U.S.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
United States v. DePuy Orthopaedics, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-depuy-orthopaedics-inc-mad-2021.